UBS Group AG - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$458,329
-16.9%
11,111
+12.4%
0.00%
Q2 2023$551,866
-56.0%
9,883
-56.0%
0.00%
Q1 2023$1,253,712
+602.6%
22,472
+358.9%
0.00%
Q4 2022$178,447
+236.7%
4,897
+162.2%
0.00%
Q3 2022$53,000
-59.8%
1,868
-36.3%
0.00%
Q2 2022$132,000
-92.8%
2,933
-87.7%
0.00%
-100.0%
Q1 2022$1,822,000
-60.7%
23,941
-23.0%
0.00%0.0%
Q4 2021$4,631,000
+9.5%
31,091
+7.1%
0.00%0.0%
Q3 2021$4,228,000
-12.9%
29,042
+17.1%
0.00%
-50.0%
Q2 2021$4,856,000
-11.5%
24,797
-18.2%
0.00%0.0%
Q1 2021$5,489,000
+6.3%
30,327
-16.8%
0.00%0.0%
Q4 2020$5,165,000
-35.7%
36,472
-43.4%
0.00%
-33.3%
Q3 2020$8,036,000
+104.6%
64,452
+46.5%
0.00%
+200.0%
Q2 2020$3,928,000
+122.4%
43,981
+55.1%
0.00%0.0%
Q1 2020$1,766,000
-4.2%
28,359
+17.2%
0.00%0.0%
Q4 2019$1,844,000
+3446.2%
24,199
+2233.6%
0.00%
Q3 2019$52,0001,0370.00%
Other shareholders
10X GENOMICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Venrock Management VI, LLC 8,185,565$952,538,00099.56%
Foresite Capital Management I, LLC 2,750,000$342,870,00096.54%
Foresite Capital Management II, LLC 3,503,528$436,820,00095.05%
12 West Capital Management LP 1,922,000$239,635,00011.66%
FINANCIAL CONSULATE, INC 163,366$20,368,0009.67%
JS Capital Management LLC 606,400$75,606,0003.91%
Asymmetry Capital Management, L.P. 43,512$5,425,0003.49%
Pinz Capital Management, LP 55,400$6,907,0002.52%
HAMILTON LANE ADVISORS LLC 37,087$4,624,0002.24%
RTW INVESTMENTS, LP 660,933$82,405,0001.98%
View complete list of 10X GENOMICS INC shareholders